Here are three things to know:
1. The fiber-based material is bound by a biodegradable polymer.
2. The company will seek additional funding and potential commercialization partners for its orthopedic surgical products.
3. The privately held company aims to eliminate the need for future implantation.
More articles on biologics:
Bone Biologics raises $5.9M: 3 notes
Viscogliosi Brothers to purchase Bioventus’ BMP development program: 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
